Advertisement

Epigenetic Regulation of the Kappa Opioid Receptor by Child Abuse

      Abstract

      Background

      Experiences of abuse and neglect during childhood are major predictors of the emergence of depressive and suicidal behaviors throughout life. The underlying biological mechanisms, however, remain poorly understood. Here, we focused on the opioid system as a potential brain substrate mediating these effects.

      Methods

      Postmortem samples from three brain structures regulating social bonds and emotions were analyzed. Groups were constituted of depressed individuals who died by suicide, with or without a history of severe child abuse, and of psychiatrically healthy control subjects. Expression of opioid peptides and receptors was measured using real-time polymerase chain reaction. DNA methylation, a major epigenetic mark, was investigated using targeted bisulfite sequencing and characterized at functional level using in vitro reporter assays. Finally, oxidative bisulfite sequencing was used to differentiate methylation and hydroxymethylation of DNA.

      Results

      A history of child abuse specifically associated in the anterior insula with a downregulation of the kappa opioid receptor (Kappa), as well as decreased DNA methylation in the second intron of the Kappa gene. In vitro assays further showed that this intron functions as a genomic enhancer where glucocorticoid receptor binding regulates Kappa expression, unraveling a new mechanism mediating the well-established interactions between endogenous opioids and stress. Finally, results showed that child abuse is associated in the Kappa intron with a selective reduction in levels of DNA hydroxymethylation, likely mediating the observed downregulation of the receptor.

      Conclusions

      Altogether, our findings uncover new facets of Kappa physiology, whereby this receptor may be epigenetically regulated by stressful experiences, in particular as a function of early social life.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Meyer-Lindenberg A.
        • Tost H.
        Neural mechanisms of social risk for psychiatric disorders.
        Nat Neurosci. 2012; 15: 663-668
        • Eisenberger N.I.
        Social ties and health: A social neuroscience perspective.
        Curr Opin Neurobiol. 2013; 23: 407-413
        • Panksepp J.B.
        • Lahvis G.P.
        Rodent empathy and affective neuroscience.
        Neurosci Biobehav Rev. 2011; 35: 1864-1875
        • Lutz P.E.
        • Kieffer B.L.
        Opioid receptors: Distinct roles in mood disorders.
        Trends Neurosci. 2013; 36: 195-206
        • Panksepp J.
        • Panksepp J.B.
        Toward a cross-species understanding of empathy.
        Trends Neurosci. 2013; 36: 489-496
        • Barr C.S.
        • Schwandt M.L.
        • Lindell S.G.
        • Higley J.D.
        • Maestripieri D.
        • Goldman D.
        • et al.
        Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates.
        Proc Natl Acad Sci U S A. 2008; 105: 5277-5281
        • Moles A.
        • Kieffer B.L.
        • D'Amato F.R.
        Deficit in attachment behavior in mice lacking the mu-opioid receptor gene.
        Science. 2004; 304: 1983-1986
        • Trezza V.
        • Baarendse P.J.
        • Vanderschuren L.J.
        The pleasures of play: Pharmacological insights into social reward mechanisms.
        Trends Pharmacol Sci. 2010; 31: 463-469
        • Cole S.L.
        • Hofford R.S.
        • Evert D.J.
        • Wellman P.J.
        • Eitan S.
        Social influences on morphine conditioned place preference in adolescent mice.
        Addict Biol. 2013; 18: 274-285
        • Kennedy B.C.
        • Panksepp J.B.
        • Runckel P.A.
        • Lahvis G.P.
        Social influences on morphine-conditioned place preference in adolescent BALB/cJ and C57BL/6J mice.
        Psychopharmacology (Berl). 2012; 219: 923-932
        • Briand L.A.
        • Hilario M.
        • Dow H.C.
        • Brodkin E.S.
        • Blendy J.A.
        • Berton O.
        Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat.
        J Neurosci. 2015; 35: 3582-3590
        • Karkhanis A.N.
        • Rose J.H.
        • Weiner J.L.
        • Jones S.R.
        Early-life social isolation stress increases kappa opioid receptor responsiveness and downregulates the dopamine system.
        Neuropsychopharmacology. 2016; 41: 2263-2274
        • Resendez S.L.
        • Kuhnmuench M.
        • Krzywosinski T.
        • Aragona B.J.
        κ-Opioid receptors within the nucleus accumbens shell mediate pair bond maintenance.
        J Neurosci. 2012; 32: 6771-6784
        • Higham J.P.
        • Barr C.S.
        • Hoffman C.L.
        • Mandalaywala T.M.
        • Parker K.J.
        • Maestripieri D.
        Mu-opioid receptor (OPRM1) variation, oxytocin levels and maternal attachment in free-ranging rhesus macaques Macaca mulatta.
        Behav Neurosci. 2011; 125: 131-136
        • Hsu D.T.
        • Sanford B.J.
        • Meyers K.K.
        • Love T.M.
        • Hazlett K.E.
        • Walker S.J.
        • et al.
        It still hurts: Altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
        Mol Psychiatry. 2015; 20: 193-200
        • Hsu D.T.
        • Sanford B.J.
        • Meyers K.K.
        • Love T.M.
        • Hazlett K.E.
        • Wang H.
        • et al.
        Response of the μ-opioid system to social rejection and acceptance.
        Mol Psychiatry. 2013; 18: 1211-1217
        • Inagaki T.K.
        • Ray L.A.
        • Irwin M.R.
        • Way B.M.
        • Eisenberger N.I.
        Opioids and social bonding: Naltrexone reduces feelings of social connection.
        Soc Cogn Affect Neurosci. 2016; 11: 728-735
        • Way B.M.
        • Taylor S.E.
        • Eisenberger N.I.
        Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection.
        Proc Natl Acad Sci U S A. 2009; 106: 15079-15084
        • Cole P.M.
        • Michel M.K.
        • Teti L.O.
        The development of emotion regulation and dysregulation: A clinical perspective.
        Monogr Soc Res Child Dev. 1994; 59: 73-100
        • Heller A.S.
        • Casey B.J.
        The neurodynamics of emotion: Delineating typical and atypical emotional processes during adolescence.
        Dev Sci. 2016; 19: 3-18
        • Teicher M.H.
        • Samson J.A.
        Annual Research Review: Enduring neurobiological effects of childhood abuse and neglect.
        J Child Psychol Psychiatry. 2016; 57: 241-266
        • Green J.G.
        • McLaughlin K.A.
        • Berglund P.A.
        • Gruber M.J.
        • Sampson N.A.
        • Zaslavsky A.M.
        • Kessler R.C.
        Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: Associations with first onset of DSM-IV disorders.
        Arch Gen Psychiatry. 2010; 67: 113-123
        • Gilbert R.
        • Widom C.S.
        • Browne K.
        • Fergusson D.
        • Webb E.
        • Janson S.
        Burden and consequences of child maltreatment in high-income countries.
        Lancet. 2009; 373: 68-81
        • Nemeroff C.B.
        Paradise Lost: The neurobiological and clinical consequences of child abuse and neglect.
        Neuron. 2016; 89: 892-909
        • Meaney M.J.
        • Szyf M.
        Maternal care as a model for experience-dependent chromatin plasticity?.
        Trends Neurosci. 2005; 28: 456-463
        • Lutz P.E.
        • Turecki G.
        DNA methylation and childhood maltreatment: From animal models to human studies.
        Neuroscience. 2014; 264: 142-156
        • Wei L.N.
        • Loh H.H.
        Transcriptional and epigenetic regulation of opioid receptor genes: Present and future.
        Annu Rev Pharmacol Toxicol. 2011; 51: 75-97
        • Booth M.J.
        • Branco M.R.
        • Ficz G.
        • Oxley D.
        • Krueger F.
        • Reik W.
        • Balasubramanian S.
        Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution.
        Science. 2012; 336: 934-937
        • Dumais A.
        • Lesage A.D.
        • Alda M.
        • Rouleau G.
        • Dumont M.
        • Chawky N.
        • et al.
        Risk factors for suicide completion in major depression: A case-control study of impulsive and aggressive behaviors in men.
        Am J Psychiatry. 2005; 162: 2116-2124
        • Brewin C.R.
        • Andrews B.
        • Gotlib I.H.
        Psychopathology and early experience: A reappraisal of retrospective reports.
        Psychol Bull. 1993; 113: 82-98
        • Conner K.R.
        • Conwell Y.
        • Duberstein P.R.
        The validity of proxy-based data in suicide research: A study of patients 50 years of age and older who attempted suicide. II. Life events, social support and suicidal behavior.
        Acta Psychiatr Scand. 2001; 104: 452-457
        • Hawton K.
        • Appleby L.
        • Platt S.
        • Foster T.
        • Cooper J.
        • Malmberg A.
        • Simkin S.
        The psychological autopsy approach to studying suicide: A review of methodological issues.
        J Affect Disord. 1998; 50: 269-276
        • Kelly T.M.
        • Mann J.J.
        Validity of DSM-III-R diagnosis by psychological autopsy: A comparison with clinician ante-mortem diagnosis.
        Acta Psychiatr Scand. 1996; 94: 337-343
        • McGirr A.
        • Tousignant M.
        • Routhier D.
        • Pouliot L.
        • Chawky N.
        • Margolese H.C.
        • Turecki G.
        Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders: A case-control study.
        Schizophr Res. 2006; 84: 132-143
        • Brent D.A.
        • Perper J.A.
        • Moritz G.
        • Allman C.J.
        • Roth C.
        • Schweers J.
        • Balach L.
        The validity of diagnoses obtained through the psychological autopsy procedure in adolescent suicide victims: Use of family history.
        Acta Psychiatr Scand. 1993; 87: 118-122
        • Bifulco A.
        • Brown G.W.
        • Harris T.O.
        Childhood Experience of Care and Abuse (CECA): A retrospective interview measure.
        J Child Psychol Psychiatry. 1994; 35: 1419-1435
        • Bifulco A.
        • Brown G.W.
        • Lillie A.
        • Jarvis J.
        Memories of childhood neglect and abuse: Corroboration in a series of sisters.
        J Child Psychol Psychiatry. 1997; 38: 365-374
        • Lutz P.E.
        • Zhou Y.
        • Labbe A.
        • Mechawar N.
        • Turecki G.
        Decreased expression of nociceptin/orphanin FQ in the dorsal anterior cingulate cortex of suicides.
        Eur Neuropsychopharmacol. 2015; 25: 2008-2014
        • Masser D.R.
        • Berg A.S.
        • Freeman W.M.
        Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing.
        Epigenetics Chromatin. 2013; 6: 33
        • Feng J.
        • Shao N.
        • Szulwach K.E.
        • Vialou V.
        • Huynh J.
        • Zhong C.
        • et al.
        Role of Tet1 and 5-hydroxymethylcytosine in cocaine action.
        Nat Neurosci. 2015; 18: 536-544
        • Chen G.G.
        • Gross J.A.
        • Lutz P.E.
        • Vaillancourt K.
        • Maussion G.
        • Bramoulle A.
        • et al.
        Medium throughput bisulfite sequencing for accurate detection of 5-methylcytosine and 5-hydroxymethylcytosine.
        BMC Genomics. 2017; 18: 96
        • Bolger A.M.
        • Lohse M.
        • Usadel B.
        Trimmomatic: A flexible trimmer for Illumina sequence data.
        Bioinformatics. 2014; 30: 2114-2120
        • Krueger F.
        • Andrews S.R.
        Bismark: A flexible aligner and methylation caller for Bisulfite-Seq applications.
        Bioinformatics. 2011; 27: 1571-1572
        • Lev Maor G.
        • Yearim A.
        • Ast G.
        The alternative role of DNA methylation in splicing regulation.
        Trends Genet. 2015; 31: 274-280
        • Tukey J.W.
        Comparing individual means in the analysis of variance.
        Biometrics. 1949; 5: 99-114
        • McGowan P.O.
        • Sasaki A.
        • D'Alessio A.C.
        • Dymov S.
        • Labonte B.
        • Szyf M.
        • et al.
        Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.
        Nat Neurosci. 2009; 12: 342-348
        • Klengel T.
        • Mehta D.
        • Anacker C.
        • Rex-Haffner M.
        • Pruessner J.C.
        • Pariante C.M.
        • et al.
        Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions.
        Nat Neurosci. 2013; 16: 33-41
        • Turecki G.
        • Meaney M.J.
        Effects of the social environment and stress on glucocorticoid receptor gene methylation: A systematic review.
        Biol Psychiatry. 2016; 79: 87-96
        • Lalanne L.
        • Ayranci G.
        • Kieffer B.L.
        • Lutz P.E.
        The kappa opioid receptor: from addiction to depression, and back.
        Front Psychiatry. 2014; 5: 170
        • Bruchas M.R.
        • Land B.B.
        • Chavkin C.
        The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
        Brain Res. 2010; 1314: 44-55
        • Knoll A.T.
        • Carlezon Jr., W.A.
        Dynorphin, stress, and depression.
        Brain Res. 2010; 1314: 56-73
        • Mellen M.
        • Ayata P.
        • Dewell S.
        • Kriaucionis S.
        • Heintz N.
        MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system.
        Cell. 2012; 151: 1417-1430
        • Gross J.A.
        • Pacis A.
        • Chen G.G.
        • Barreiro L.B.
        • Ernst C.
        • Turecki G.
        Characterizing 5-hydroxymethylcytosine in human prefrontal cortex at single base resolution.
        BMC Genomics. 2015; 16: 672
        • Lister R.
        • Mukamel E.A.
        • Nery J.R.
        • Urich M.
        • Puddifoot C.A.
        • Johnson N.D.
        • et al.
        Global epigenomic reconfiguration during mammalian brain development.
        Science. 2013; 341: 1237905
        • Mo A.
        • Mukamel E.A.
        • Davis F.P.
        • Luo C.
        • Henry G.L.
        • Picard S.
        • et al.
        Epigenomic signatures of neuronal diversity in the mammalian brain.
        Neuron. 2015; 86: 1369-1384
        • Wen L.
        • Li X.
        • Yan L.
        • Tan Y.
        • Li R.
        • Zhao Y.
        • et al.
        Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain.
        Genome Biol. 2014; 15: R49
        • Pacis A.
        • Tailleux L.
        • Morin A.M.
        • Lambourne J.
        • MacIsaac J.L.
        • Yotova V.
        • et al.
        Bacterial infection remodels the DNA methylation landscape of human dendritic cells.
        Genome Res. 2015; 25: 1801-1811
        • Guo J.U.
        • Su Y.
        • Zhong C.
        • Ming G.L.
        • Song H.
        Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.
        Cell. 2011; 145: 423-434
        • Yu M.
        • Hon G.C.
        • Szulwach K.E.
        • Song C.X.
        • Zhang L.
        • Kim A.
        • et al.
        Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome.
        Cell. 2012; 149: 1368-1380
        • Copeland W.E.
        • Sun H.
        • Costello E.J.
        • Angold A.
        • Heilig M.A.
        • Barr C.S.
        Child mu-opioid receptor gene variant influences parent-child relations.
        Neuropsychopharmacology. 2011; 36: 1165-1170
        • Resendez S.L.
        • Aragona B.J.
        Aversive motivation and the maintenance of monogamous pair bonding.
        Rev Neurosci. 2013; 24: 51-60
        • Ploj K.
        • Nylander I.
        Long-term effects on brain opioid and opioid receptor like-1 receptors after short periods of maternal separation in rats.
        Neurosci Lett. 2003; 345: 195-197
        • Ploj K.
        • Roman E.
        • Nylander I.
        Long-term effects of maternal separation on ethanol intake and brain opioid and dopamine receptors in male Wistar rats.
        Neuroscience. 2003; 121: 787-799
        • Bruchas M.R.
        • Schindler A.G.
        • Shankar H.
        • Messinger D.I.
        • Miyatake M.
        • Land B.B.
        • et al.
        Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.
        Neuron. 2011; 71: 498-511
        • McLaughlin J.P.
        • Li S.
        • Valdez J.
        • Chavkin T.A.
        • Chavkin C.
        Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system.
        Neuropsychopharmacology. 2006; 31: 1241-1248
        • Land B.B.
        • Bruchas M.R.
        • Lemos J.C.
        • Xu M.
        • Melief E.J.
        • Chavkin C.
        The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
        J Neurosci. 2008; 28: 407-414
        • Beardsley P.M.
        • Howard J.L.
        • Shelton K.L.
        • Carroll F.I.
        Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats.
        Psychopharmacology (Berl). 2005; 183: 118-126
        • Polter A.M.
        • Bishop R.A.
        • Briand L.A.
        • Graziane N.M.
        • Pierce R.C.
        • Kauer J.A.
        Poststress block of kappa opioid peceptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking.
        Biol Psychiatry. 2014; 76: 785-793
        • Flaisher-Grinberg S.
        • Persaud S.D.
        • Loh H.H.
        • Wei L.N.
        Stress-induced epigenetic regulation of kappa-opioid receptor gene involves transcription factor c-Myc.
        Proc Natl Acad Sci U S A. 2012; 109: 9167-9172
        • Falcon E.
        • Maier K.
        • Robinson S.A.
        • Hill-Smith T.E.
        • Lucki I.
        Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice.
        Psychopharmacology (Berl). 2015; 232: 907-915
        • Huang P.
        • Tunis J.
        • Parry C.
        • Tallarida R.
        • Liu-Chen L.Y.
        Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.
        Eur J Pharmacol. 2016; 781: 53-59
        • Yovell Y.
        • Bar G.
        • Mashiah M.
        • Baruch Y.
        • Briskman I.
        • Asherov J.
        • et al.
        Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: A randomized controlled trial.
        Am J Psychiatry. 2016; 173: 491-498
        • Harrison C.
        Trial watch: Opioid receptor blocker shows promise in Phase II depression trial.
        Nat Rev Drug Discov. 2013; 12: 415
        • Ehrich E.
        • Turncliff R.
        • Du Y.
        • Leigh-Pemberton R.
        • Fernandez E.
        • Jones R.
        • Fava M.
        Evaluation of opioid modulation in major depressive disorder.
        Neuropsychopharmacology. 2015; 40: 1448-1455
        • Falcon E.
        • Browne C.A.
        • Leon R.M.
        • Fleites V.C.
        • Sweeney R.
        • Kirby L.G.
        • Lucki I.
        Antidepressant-like effects of buprenorphine are mediated by kappa opioid receptors.
        Neuropsychopharmacology. 2016; 41: 2344-2351
        • Wee S.
        • Koob G.F.
        The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
        Psychopharmacology (Berl). 2010; 210: 121-135
        • Kreek M.J.
        • Zhou Y.
        • Butelman E.R.
        • Levran O.
        Opiate and cocaine addiction: From bench to clinic and back to the bench.
        Curr Opin Pharmacol. 2009; 9: 74-80
        • Muschamp J.W.
        • Hollander J.A.
        • Thompson J.L.
        • Voren G.
        • Hassinger L.C.
        • Onvani S.
        • et al.
        Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.
        Proc Natl Acad Sci U S A. 2014; 111: E1648-E1655
        • Pietrzak R.H.
        • Naganawa M.
        • Huang Y.
        • Corsi-Travali S.
        • Zheng M.Q.
        • Stein M.B.
        • et al.
        Association of in vivo kappa-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.
        JAMA Psychiatry. 2014; 71: 1262-1270
        • Lamm C.
        • Singer T.
        The role of anterior insular cortex in social emotions.
        Brain Struct Funct. 2010; 214: 579-591